Sacubitril/valsartan as a Treatment for Resistant Hypertension in Patients With Heart Failure and Preserved Ejection Fraction

被引：0
|
作者：
Jhund, Pardeep S.
Alice, M.
Pfeffer, Marc A.
Zannad, Faiez
Lefkowitz, Martin P.
Shi, Victor
Vardeny, Orly
Solomon, Scott
McMurray, John J.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16477
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Study on the efficacy of sacubitril/valsartan in patients with heart failure with preserved ejection fraction undergoing peritoneal dialysis
    Sheng, Yuping
    Ma, Xiaoying
    Liu, Ye
    Yang, Xingmeng
    Sun, Fuyun
    CARDIOLOGY, 2023, 148 (05) : 385 - 394
  • [32] Effect on the Quality of Life of Patients with Heart Failure and Reduced/Preserved Ejection Fraction Using Sacubitril/Valsartan
    Huang, Yuanrui
    Wu, Xu
    Li, Xingyu
    Liu, Zhengzhong
    Li, Yunyi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (08)
  • [33] Efficacy of Sacubitril-Valsartan on heart failure with preserved ejection fraction and atrial fibrillation in female patients
    Liu, Xiang
    Qiao, Zhenguo
    Zheng, Ju
    Ye, Fulong
    You, Hua
    Wu, Yanming
    KUWAIT MEDICAL JOURNAL, 2025, 57 (01):
  • [34] Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
    Lupon, Josep
    Santiago-Vacas, Evelyn
    Cediel, German
    Codina, Pau
    Domingo, Mar
    Revuelta-Lopez, Elena
    Zamora, Elisabet
    Spitaleri, Giosafat
    Santesmases, Javier
    Nunez, Julio
    Bayes-Genis, Antoni
    PLOS ONE, 2021, 16 (05):
  • [35] Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction
    Foa, Alberto
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Pabon, Maria A.
    Lu, Henri
    Pfeffer, Marc A.
    Packer, Milton
    Vardeny, Orly
    Rouleau, Jean L.
    Lefkowitz, Martin
    Mentz, Robert J.
    Jhund, Pardeep S.
    Desai, Akshay S.
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (18) : 1731 - 1739
  • [36] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [37] Prior Heart Failure Hospitalization, Clinical Outcomes, and Effect of Sacubitril/Valsartan Compared With Valsartan in Heart Failure With Preserved Ejection Fraction
    Vaduganathan, Muthiah
    Claggett, Brian
    Anker, Stefan D.
    Perrone, Sergio V., Sr.
    Janssens, Stefan P.
    Milicic, Davor
    Arango, Juan L.
    Packer, Milton
    McMurray, John J.
    Solomon, Scott
    CIRCULATION, 2019, 140 (25) : E995 - E996
  • [38] Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction
    ul Haq, Muhammad Asrar
    Hare, David L.
    Wong, Chiew
    Hayat, Umair
    Barlis, Peter
    CURRENT HYPERTENSION REVIEWS, 2014, 10 (03) : 142 - 148
  • [39] Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction
    Rossignol, Patrick
    Claggett, Brian Lee
    Liu, Jiankang
    Vardeny, Orly
    Pitt, Bertram
    Zannad, Faiez
    Solomon, Scott
    AMERICAN JOURNAL OF HYPERTENSION, 2018, 31 (04) : 407 - 414
  • [40] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
12345